Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             42 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A European perspective on haematopoietic growth factors in haemato-oncology: Report of an expert meeting of the EORTC Croockewit, A.J.
 1997
 33 11 p. 1732-1746
15 p.
 artikel
2 An intronic germline transition in the HNPCC gene hMSH2 is associated with sporadic colorectal cancer Goessl, C.
 1997
 33 11 p. 1869-1874
6 p.
 artikel
3 Baseline quality of life of patients with advanced prostate cancer Curran, D.
 1997
 33 11 p. 1809-1814
6 p.
 artikel
4 Calendar of forthcoming meetings 1997
 33 11 p. I-III
nvt p.
 artikel
5 c-erbB-3 protein expression in ductal carcinoma in situ of the breast Bobrow, L.G.
 1997
 33 11 p. 1846-1850
5 p.
 artikel
6 Cervical cancer mortality in Belgium, 1955–1989. A descriptive study Vyslouzilova, S.
 1997
 33 11 p. 1841-1845
5 p.
 artikel
7 Cisplatin pharmacokinetics in children with cancer Peng, B.
 1997
 33 11 p. 1823-1828
6 p.
 artikel
8 Combined effects of cisplatin and N, N-diethyl-2-[4- (phenylmethyl) phenoxy] ethanamine HC1 on the growth of human ovarian cancer xenografts in nude mice Hiramatsu, H.
 1997
 33 11 p. 1904-1905
2 p.
 artikel
9 Comments on p53 protein expression, cell proliferation and steroid hormone receptors in ductal and lobular in situ carcinomas of the Breast Rudas et al., Eur.E. Cancer 1997, 33, No. 1, 39–44 Schmitt, F.C.
 1997
 33 11 p. 1903-
1 p.
 artikel
10 Correction 1997
 33 11 p. 1907-
1 p.
 artikel
11 Effectiveness of paclitaxel and carboplatin combination in heavily pretreated patients with head and neck cancers Stathopoulos, G.P.
 1997
 33 11 p. 1780-1783
4 p.
 artikel
12 Efficacy and mechanism of aluminium phthalocyanine and its sulphonated derivatives mediated photodynamic therapy on murine tumours Chan, W.-S.
 1997
 33 11 p. 1855-1859
5 p.
 artikel
13 Epirubicin and etoposide combination chemotherapy to treat hepatocellular carcinoma patients: a phase II study Bobbio-Pallavicini, E.
 1997
 33 11 p. 1784-1788
5 p.
 artikel
14 Experimental Antitumour Activity of S 16020-2 in a Panel of Human Tumours Kraus-Berthier, L.
 1997
 33 11 p. 1881-1887
7 p.
 artikel
15 Expression of two 50 kDa proteins is associated with sensitivity towards etherlipid analogues in the human leukaemia cell line HL 60 Berkovic, D.
 1997
 33 11 p. 1875-1880
6 p.
 artikel
16 5-Fluorouracil (5-FU) continuous intravenous infusion compared with bolus administration. final results of a randomised trial in metastatic colorectal cancer Rougier, Ph.
 1997
 33 11 p. 1789-1793
5 p.
 artikel
17 Frequent detection of mutations in the 5' flanking region of the prostate-specific antigen gene in female breast cancer Tsuyuki, D.
 1997
 33 11 p. 1851-1854
4 p.
 artikel
18 Higher doses of α-interferon do not increase the activity of the weekly cisplatin-interferon combination in advanced malignant mesothelioma Trandafir, L.
 1997
 33 11 p. 1900-1902
3 p.
 artikel
19 Incidence of second primary cancers in three Italian population-based cancer registries Buiatti, E.
 1997
 33 11 p. 1829-1834
6 p.
 artikel
20 International cancer news 1997
 33 11 p. 1711-1716
6 p.
 artikel
21 Lymph node sonography versus palpation for detecting recurrent disease in patients with malignant melanoma Binder, M.
 1997
 33 11 p. 1805-1808
4 p.
 artikel
22 Management and survival of ovarian cancer patients in South East England Wolfe, C.D.A.
 1997
 33 11 p. 1835-1840
6 p.
 artikel
23 Metallothionein and Fas (CD95) are expressed in squamous cell carcinoma of the tongue Sundelin, K.
 1997
 33 11 p. 1860-1864
5 p.
 artikel
24 Modem brachytherapy: Current state and future prospects Nickers, P.
 1997
 33 11 p. 1747-1751
5 p.
 artikel
25 Modulation of 5-fluorouracil with methotrexate and low-dose N-(phosphonacetyl)-l-aspartate in patients with advanced colorectal cancer. Results of a phase II study Köhne, C.-H.
 1997
 33 11 p. 1896-1899
4 p.
 artikel
26 No evidence of known types of human papillomavirus in squamous cell cancer of the oesophagus in a low-risk area Kok, T.C.
 1997
 33 11 p. 1865-1868
4 p.
 artikel
27 On the current management of osteosarcoma. A critical evaluation and a proposal for a modified treatment strategy Bruland, Ø.S.
 1997
 33 11 p. 1725-1731
7 p.
 artikel
28 Paclitaxel by 3-H infusion and carboplatin in anthracycline-resistant advanced breast cancer. A phase II study conducted by the hellenic cooperative oncology group Fountzilas, G.
 1997
 33 11 p. 1893-1895
3 p.
 artikel
29 Paclitaxel in recurrent ovarian cancer: Better upfront? Comments on: A phase II study of paclitaxel in platinum pretreated ovarian cancer. A hellenic cooperative oncology group study. EurJ Cancer 1977, 33, 160–163. Bulusu, V.R.
 1997
 33 11 p. 1905-1906
2 p.
 artikel
30 Phase II study of 21 day schedule oral etoposide in children Davidson, A.
 1997
 33 11 p. 1816-1822
7 p.
 artikel
31 Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: Results of a multicentre randomised trial Gregor, A.
 1997
 33 11 p. 1752-1758
7 p.
 artikel
32 Response from Rudas and associates Rudas, M.
 1997
 33 11 p. 1904-
1 p.
 artikel
33 Role of recombinant interferon-gamma maintenance in responding patients with small cell lung cancer. A randomised phase iii study of the eortc lung cancer cooperative group Zandwijk, N.van
 1997
 33 11 p. 1759-1766
8 p.
 artikel
34 Serum interleukin-6 in relation to acute-phase reactants and survival in patients with renal cell carcinoma Ljungberg, B.
 1997
 33 11 p. 1794-1798
5 p.
 artikel
35 Should adjuvant chemotherapy be used to treat breast cancer in elderly patients (≥ 70 years of age)? Fentiman, I.S.
 1997
 33 11 p. 1722-1723
2 p.
 artikel
36 Should adjuvant chemotherapy be used to treat breast cancer in elderly patients (≥ 70 years of age)? Monfardini, S.
 1997
 33 11 p. 1723-1724
2 p.
 artikel
37 Should adjuvant chemotherapy be used to treat breast cancer in elderly patients (≥ 70 years of age)? Balducci, L.
 1997
 33 11 p. 1720-1722
3 p.
 artikel
38 Small cell lung cancer and prophylactic cranial irradiation (PCI): Perhaps the question is not who needs PCI but who wants PCI? Le Chevalier, T.
 1997
 33 11 p. 1717-1719
3 p.
 artikel
39 Stochastic relationship between the growth fraction and vascularity of thin malignant melanomas Piérard, G.E.
 1997
 33 11 p. 1888-1892
5 p.
 artikel
40 The clinical relevance of static disease (no change) category for 6 months on endocrine therapy in patients with breast cancer Robertson, J.F.R.
 1997
 33 11 p. 1774-1779
6 p.
 artikel
41 The impact of tumour angiogenesis, p53 overexpression and proliferative activity (MIB-1) on survival in squamous cervical carcinoma Åvall-Lundqvist, E.H.
 1997
 33 11 p. 1799-1804
6 p.
 artikel
42 Third-line hormonal treatment with exemestane in postmenopausal patients with advanced breast cancer progressing on aminoglutethimide: a phase ii multicentre multinational study Thürlimann, B.
 1997
 33 11 p. 1767-1773
7 p.
 artikel
                             42 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland